70 papers
Cardiovascular medicine focuses on the heart and blood vessels, exploring how to prevent, diagnose, and treat conditions that affect our circulation. This vital field ranges from understanding high blood pressure and heart failure to investigating the latest breakthroughs in surgical techniques and lifestyle interventions. Because these discoveries directly impact public health, staying informed about emerging research is more important than ever for both specialists and curious readers.
At Gist.Science, we process every new preprint in this category as it appears on medRxiv, ensuring you have immediate access to the latest findings before they undergo formal peer review. For each study, we provide both a plain-language explanation to clarify the core concepts and a detailed technical summary for those seeking deeper scientific context. Below are the latest papers in cardiovascular medicine, organized to help you navigate the most recent developments shaping the future of heart health.
This real-world study utilizing US claims data demonstrates that, compared to tafamidis, the newly approved TTR stabilizer acoramidis significantly reduces the risk of diuretic intensification and a composite of diuretic intensification, heart failure hospitalization, and mortality in patients with newly treated ATTR-CM.
This paper introduces the concept of a "myocardial tug-of-war" at the mesoscale, where mechanical interactions between differently contracting myocardial units determine left ventricular efficiency and adaptability in healthy hearts, but contribute to functional decline following myocardial infarction.
This UK Biobank cohort study of over 386,000 participants reveals that central adiposity, specifically measured by waist circumference and waist-to-height ratio, is a robust independent predictor of incident infective endocarditis, with risk significantly elevated in younger individuals who have both abdominal obesity and diabetes.
This study demonstrates that women with a history of preterm pre-eclampsia exhibit significant cardiometabolic morbidity, including hypertension and myocardial fibrosis, 3–6 years postpartum, with early postnatal blood pressure, weight, and biomarker profiles serving as predictors for these long-term cardiovascular risks.
This study demonstrates the feasibility of fine-tuning the InternVL2-4B Vision-Language Model to automate coronary angiogram interpretation and report generation, achieving moderate performance in stenosis detection, anatomy labeling, and clinical report synthesis to potentially assist cardiologists in improving diagnostic efficiency and resource-limited care.
In a cross-sectional study of 57 adults with sickle cell disease in Colombia, echocardiographic analysis revealed that while biventricular structure and function were largely preserved, nearly one-third of patients exhibited signs suggestive of pulmonary hypertension, supporting the routine use of echocardiography for early cardiovascular risk stratification in this population.
This paper demonstrates that applying supplemental frequentist and Bayesian analyses to a randomized controlled trial on coffee and atrial fibrillation reveals that while the original findings were statistically significant, they likely suffer from type M error and offer only modest probabilities of clinically meaningful benefit, thereby highlighting the importance of robustness checks for unexpected trial results.
One year after coronary artery bypass grafting, patients exhibit a consistent deterioration in the mechanical properties of left ventricular diastolic filling, including increased myocardial stiffness and damping, despite preserved ejection fraction.
This paper argues that the cardiovascular benefits of alirocumab in the ODYSSEY Outcomes trial are primarily driven by lipoprotein(a) reduction rather than LDL-C lowering, suggesting that the clinical importance of Lp(a) is underestimated and that future Lp(a)-targeted therapies could achieve unprecedented reductions in major adverse cardiovascular events.
This paper proposes a hybrid generative framework combining spectral-guided cVAE, latent DDPM, and a quantum-based refinement module to synthesize minority ECG classes, thereby significantly improving arrhythmia classification performance on imbalanced clinical datasets.